December 01, 2016
This World AIDS Day, women have reason to be optimistic that a new era may be at hand – one in which they could have more choices to protect themselves against HIV. Earlier this year, a novel monthly vaginal ring developed by the International Partnership for Microbicides became the first long-acting method to show efficacy in two Phase III clinical trials. Watch this video to learn about the dapivirine ring and IPM's next steps to potentially...
November 07, 2016
Products called microbicides offer women new hope against HIV, especially in sub-Saharan Africa, where women bear the burden of the epidemic.A monthly vaginal ring that releases a drug for HIV prevention was recently shown to safely help reduce the risk of infection and could give women a novel way to protect themselves. Learn about the latest research and next steps for the dapivirine ring, developed by the International Partnership for...
July 18, 2016
Watch this short clip from MSN summarizing the data on IPM's dapivirine ring announced at the 2016 International AIDS Conference. Length: approximately 30 seconds
May 19, 2016
Dr. Zeda Rosenberg, IPM’s chief executive officer, talks with Erin Houston of Devex at the Women Deliver 2016 conference about IPM’s public-private partnership model, promising HIV prevention products for women like IPM’s monthly dapivirine vaginal ring and next steps for the ring. Length: approximately 15 minutes
October 01, 2015
Women and girls continue to bear the burden of the HIV/AIDS epidemic, especially in sub-Saharan Africa. New tools in development called microbicides could give women self-initiated prevention methods.Learn about the only microbicide now in efficacy trials - IPM's monthly dapivirine vaginal ring - and how women could soon have new options to protect their sexual and reproductive health.Also available in Luganda, Sepedi, Tswana, Xhosa and Zulu. ...
March 02, 2015
Dr. Zeda Rosenberg, IPM’s chief executive officer, sits with Fred Schaich, president of the International Foundation for Alternative Research in AIDS (IFARA) to discuss promising developments in HIV prevention research for women in this video from the 2015 Conference on Retroviruses and Opportunistic Infections. Length: approximately 11 minutes
July 25, 2014
Dr. Zeda Rosenberg, IPM's chief executive officer, reflects on the 20th International AIDS Conference in this video from the AIDS 2014 Live digital hub. She highlights young women in sub-Saharan Africa as a key population and discusses the importance of women-initiated products like microbicides as HIV prevention tools. Length: approximately 2 minutes
Infographic: Top Three Reasons Why the Expanded IPM-Janssen Partnership is a Boost to Women's Health
In May 2014, IPM and Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, expanded their longstanding collaboration for the development and delivery of sexual and reproductive health products containing the antiretroviral drug dapivirine. See the top reasons why this agreement is important for women.